Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] Congressional committees to seek funding for research into the deadly genetic muscle disease. Living with FSHD himself, Perez knows firsthand how dire the mission is to find a cure. And […]
[…] Society’s fellowship program aims to gain insights and achieve significant milestones into the research of FSHD, one of the most prevalent types of muscular dystrophy. Research grants most recently awarded […]
FSHD Society co-founder knew the stakes were high to get things right by Daniel Paul Perez, co-founder FSHD Society Bill Michael William G. “Bill” Michael passed peacefully at the […]
[…] “consistent” reductions in DUX4 activity along with improvements in strength and function by June Kinoshita, FSHD Society Avidity Biosciences, Inc., a San Diego-based biopharmaceutical company, announced this Wednesday, June 12, […]
[…] new era in clinical trials, what do we mean? After all, we have seen previous FSHD trials, including those by Wyeth, aTyr, Acceleron, and Fulcrum’s ReDUX4. What makes the current […]
